Humacyte Hosts Key Opinion Leader Webinar on Vascular Trauma:…
DURHAM, NC, December 13, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. HUMAa clinical-stage biotechnology platform company developing commercial-scale universally implantable bioengineered human tissue, today announced that